XML 39 R22.htm IDEA: XBRL DOCUMENT
v3.21.1

Shareholders' Equity | 12 Months Ended
--- | ---
Jan. 30, 2021
Stockholders Equity Note [Abstract] |
Shareholders' Equity |
| 13. | Shareholders’ Equity
The authorized shares of the Company consist of 125 million shares of preferred stock (“Preferred Stock”), par value of $0.01 per share, with no shares issued, and 1,000 million shares of common stock, par value of $0.01 per share, with 333.6 million shares of common stock issued and 310.5 million shares of common stock outstanding at January 30, 2021, and with 333.6 million shares of common stock issued and 309.0 million shares of common stock outstanding at February 1, 2020 (with shares held in the Company’s treasury being treated as issued, but not outstanding). No shares of common stock were retired during 2020, 2019 and 2018. Common Stock The holders of the common stock are entitled to one vote for each share held of record on all matters submitted to a vote of shareholders. Subject to preferential rights that may be applicable to any Preferred Stock, holders of common stock are entitled to receive ratably such dividends as may be declared by the Board of Directors in its discretion, out of funds legally available. Treasury Stock Treasury stock contains shares repurchased under the share repurchase program, shares repurchased to cover employee tax liabilities related to stock plan activity and shares maintained in a trust related to deferred compensation plans. Under the deferred compensation plans, shares are maintained in a trust to cover the number estimated to be needed for distribution on account of stock credits currently outstanding. Changes in the Company’s common stock issued and outstanding, including shares held by the Company’s treasury, are as follows:
|  |  |  |  |  | Treasury Stock |  |  |  |  |
|  | Common Stock Issued |  |  | Deferred Compensation Plans |  |  | Other |  |  | Total |  |  | Common Stock Outstanding |
|  | (thousands) |
Balance at February 3, 2018 |  |  | 333,606 |  |  |  | (946 | ) |  |  | (27,895 | ) |  |  | (28,841 | ) |  |  | 304,765 |
Stock issued under stock plans |  |  |  |  |  |  | (106 | ) |  |  | 2,756 |  |  |  | 2,650 |  |  |  | 2,650 |
Stock repurchases |  |  |  |  |  |  |  |  |  |  | (6 | ) |  |  | (6 | ) |  |  | (6 | )
Deferred compensation plan distributions |  |  |  |  |  |  | 111 |  |  |  |  |  |  |  | 111 |  |  |  | 111 |
Balance at February 2, 2019 |  |  | 333,606 |  |  |  | (941 | ) |  |  | (25,145 | ) |  |  | (26,086 | ) |  |  | 307,520 |
Stock issued under stock plans |  |  |  |  |  |  | (130 | ) |  |  | 1,510 |  |  |  | 1,380 |  |  |  | 1,380 |
Stock repurchases |  |  |  |  |  |  |  |  |  |  | (38 | ) |  |  | (38 | ) |  |  | (38 | )
Deferred compensation plan distributions |  |  |  |  |  |  | 169 |  |  |  |  |  |  |  | 169 |  |  |  | 169 |
Balance at February 1, 2020 |  |  | 333,606 |  |  |  | (902 | ) |  |  | (23,673 | ) |  |  | (24,575 | ) |  |  | 309,031 |
Stock issued under stock plans |  |  |  |  |  |  | (127 | ) |  |  | 1,577 |  |  |  | 1,450 |  |  |  | 1,450 |
Stock repurchases |  |  |  |  |  |  |  |  |  |  | (79 | ) |  |  | (79 | ) |  |  | (79 | )
Deferred compensation plan distributions |  |  |  |  |  |  | 98 |  |  |  |  |  |  |  | 98 |  |  |  | 98 |
Balance at January 30, 2021 |  |  | 333,606 |  |  |  | (931 | ) |  |  | (22,175 | ) |  |  | (23,106 | ) |  |  | 310,500 |
Accumulated Other Comprehensive Loss For the Company, the only component of accumulated other comprehensive loss for 2020, 2019 and 2018 relates to post employment and postretirement plan items. The net actuarial gains and losses and prior service costs and credits related to post employment and postretirement benefit plans are reclassified out of accumulated other comprehensive loss and included in the computation of net periodic benefit cost (income) and are included in benefit plan income, net in the Consolidated Statements of Operations. In addition, the Company incurred the pro-rata recognition of net actuarial losses associated with an increase in lump sum distributions associated with store closings, organizational restructuring, and periodic distribution activity as settlement charges in the Consolidated Statements of Operations. See Note 10, Retirement Plans, and Note 11, Postretirement Health Care and Life Insurance Benefits, for further information.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration